Skip Nav Destination
Issues
15 September 2017
-
Cover Image
Cover Image
The cover shows Masson Trichome staining of a section of a mammary gland treated with high-score patient-derived interstitial fluid. For details, see the article by Kenny and colleagues on page 5446 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
Editorial
CCR Translations
Review
Cancer Therapy: Clinical
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
Jean-Pierre Delord; Caroline Robert; Marta Nyakas; Grant A. McArthur; Ragini Kudchakar; Amit Mahipal; Yasuhide Yamada; Ryan Sullivan; Ana Arance; Richard F. Kefford; Matteo S. Carlino; Manuel Hidalgo; Carlos Gomez-Roca; Daniela Michel; Abdelkader Seroutou; Vassilios Aslanis; Giordano Caponigro; Darrin D. Stuart; Laure Moutouh-de Parseval; Tim Demuth; Reinhard Dummer
Author Choice
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W. Tolcher; Mario Sznol; Siwen Hu-Lieskovan; Kyriakos P. Papadopoulos; Amita Patnaik; Drew W. Rasco; Donna Di Gravio; Bo Huang; Dhiraj Gambhire; Ying Chen; Aron D. Thall; Nuzhat Pathan; Emmett V. Schmidt; Laura Q.M. Chow
Author Choice
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Paul K. Paik; Ronglai Shen; Michael F. Berger; David Ferry; Jean-Charles Soria; Alastair Mathewson; Claire Rooney; Neil R. Smith; Marie Cullberg; Elaine Kilgour; Donal Landers; Paul Frewer; Nigel Brooks; Fabrice André
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis
Araz Marachelian; Judith G. Villablanca; Cathy W. Liu; Betty Liu; Fariba Goodarzian; Hollie A. Lai; Hiroyuki Shimada; Hung C. Tran; Jaime A. Parra; Richard Gallego; Nora Bedrossian; Sabrina Young; Scarlett Czarnecki; Rebekah Kennedy; Brian D. Weiss; Kelly Goldsmith; Meaghan Granger; Katherine K. Matthay; Susan Groshen; Shahab Asgharzadeh; Richard Sposto; Robert C. Seeger
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial
Sabine Riethdorf; Volkmar Müller; Sibylle Loibl; Valentina Nekljudova; Karsten Weber; Jens Huober; Tanja Fehm; Iris Schrader; Jörn Hilfrich; Frank Holms; Hans Tesch; Christian Schem; Gunter von Minckwitz; Michael Untch; Klaus Pantel
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Didier Meulendijks; Wolfgang Jacob; Emile E. Voest; Morten Mau-Sorensen; Maria Martinez-Garcia; Alvaro Taus; Tania Fleitas; Andres Cervantes; Martijn P. Lolkema; Marlies H.G. Langenberg; Maja J. De Jonge; Stefan Sleijfer; Ji-Youn Han; Antonio Calles; Enriqueta Felip; Sang-We Kim; Jan H.M. Schellens; Sabine Wilson; Marlene Thomas; Maurizio Ceppi; Georgina Meneses-Lorente; Ian James; Suzana Vega-Harring; Rajiv Dua; Maitram Nguyen; Lori Steiner; Celine Adessi; Francesca Michielin; Birgit Bossenmaier; Martin Weisser; Ulrik N. Lassen
Personalized Medicine and Imaging
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Fanny Garlan; Pierre Laurent-Puig; David Sefrioui; Nathalie Siauve; Audrey Didelot; Nasrin Sarafan-Vasseur; Pierre Michel; Geraldine Perkins; Claire Mulot; Hélène Blons; Julien Taieb; Frederic Di Fiore; Valerie Taly; Aziz Zaanan
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Schøler; Thomas Reinert; Mai-Britt W. Ørntoft; Christine G. Kassentoft; Sigrid S. Árnadóttir; Søren Vang; Iver Nordentoft; Michael Knudsen; Philippe Lamy; Ditte Andreasen; Frank V. Mortensen; Anders R. Knudsen; Katrine Stribolt; Kim Sivesgaard; Peter Mouritzen; Hans J. Nielsen; Søren Laurberg; Torben F. Ørntoft; Claus L. Andersen
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells
Ben-Yuan Jiang; Yang-Si Li; Wei-Bang Guo; Xu-Chao Zhang; Zhi-Hong Chen; Jian Su; Wen-Zhao Zhong; Xue-Ning Yang; Jin-Ji Yang; Yang Shao; Biao Huang; Yan-Hui Liu; Qing Zhou; Hai-Yan Tu; Hua-Jun Chen; Zhen Wang; Chong-Rui Xu; Bin-Chao Wang; Shu-Yu Wu; Cun-Yi Gao; Xian Zhang; Yi-Long Wu
Cancer Therapy: Preclinical
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer
Tina Cascone; Li Xu; Heather Y. Lin; Wenbin Liu; Hai T. Tran; Yuan Liu; Kathryn Howells; Vincent Haddad; Emer Hanrahan; Monique B. Nilsson; Maria A. Cortez; Uma Giri; Humam Kadara; Babita Saigal; Yun-Yong Park; Weiyi Peng; Ju-Seog Lee; Anderson J. Ryan; Juliane M. Jüergensmeier; Roy S. Herbst; Jing Wang; Robert R. Langley; Ignacio I. Wistuba; Jack J. Lee; John V. Heymach
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
Simon J. Dovedi; Eleanor J. Cheadle; Amy L. Popple; Edmund Poon; Michelle Morrow; Ross Stewart; Erik C. Yusko; Catherine M. Sanders; Marissa Vignali; Ryan O. Emerson; Harlan S. Robins; Robert W. Wilkinson; Jamie Honeychurch; Timothy M. Illidge
Author Choice
Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer
Florian Malchers; Meryem Ercanoglu; Daniel Schütte; Roberta Castiglione; Verena Tischler; Sebastian Michels; Ilona Dahmen; Johannes Brägelmann; Roopika Menon; Johannes M. Heuckmann; Julie George; Sascha Ansén; Martin L. Sos; Alex Soltermann; Martin Peifer; Jürgen Wolf; Reinhard Büttner; Roman K. Thomas
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations
Yung-mae M. Yao; Gregory P. Donoho; Philip W. Iversen; Youyan Zhang; Robert D. Van Horn; Amelie Forest; Ruslan D. Novosiadly; Yue Wang Webster; Philip Ebert; Steven Bray; Jason C. Ting; Amit Aggarwal; James R. Henry; Ramon V. Tiu; Gregory D. Plowman; Sheng-Bin Peng
Author Choice
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Uzma S. Asghar; Alexis R. Barr; Ros Cutts; Matthew Beaney; Irina Babina; Deepak Sampath; Jennifer Giltnane; Jennifer Arca Lacap; Lisa Crocker; Amy Young; Alex Pearson; Maria Teresa Herrera-Abreu; Chris Bakal; Nicholas C. Turner
Biology of Human Tumors
ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types
Anderly C. Chüeh; Janson W.T. Tse; Michael Dickinson; Paul Ioannidis; Laura Jenkins; Lars Togel; BeeShin Tan; Ian Luk; Mercedes Davalos-Salas; Rebecca Nightingale; Matthew R. Thompson; Bryan R.G. Williams; Guillaume Lessene; Erinna F. Lee; Walter D. Fairlie; Amardeep S. Dhillon; John M. Mariadason
Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition
Bo Pang; Nan Wu; Rongwei Guan; Lin Pang; Xinlei Li; Su Li; Liudi Tang; Ying Guo; Jialei Chen; Donglin Sun; Haiming Sun; Jialin Dai; Jing Bai; Guohua Ji; Peng Liu; An Liu; Qiushi Wang; Sheng Xiao; Songbin Fu; Yan Jin
Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA In Situ Hybridization Assay
Lisha Wang; Paul W. Harms; Nallasivam Palanisamy; Shannon Carskadon; Xuhong Cao; Javed Siddiqui; Rajiv M. Patel; Sylvia Zelenka-Wang; Alison B. Durham; Douglas R. Fullen; Kelly L. Harms; Fengyun Su; Sudhanshu Shukla; Rohit Mehra; Arul M. Chinnaiyan
Author Choice
BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma
Atul Kulkarni; Husam Al-Hraishawi; Srilatha Simhadri; Kim M. Hirshfield; Suzie Chen; Sharon Pine; Chandrika Jeyamohan; Levi Sokol; Siraj Ali; Man Lung Teo; Eileen White; Lorna Rodriguez-Rodriguez; Janice M. Mehnert; Shridar Ganesan
Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
N.V. Rajeshkumar; Shinichi Yabuuchi; Shweta G. Pai; Elizabeth De Oliveira; Jurre J. Kamphorst; Joshua D. Rabinowitz; Héctor Tejero; Fátima Al-Shahrour; Manuel Hidalgo; Anirban Maitra; Chi V. Dang
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer
Filip Janku; Shile Zhang; Jill Waters; Li Liu; Helen J. Huang; Vivek Subbiah; David S. Hong; Daniel D. Karp; Siqing Fu; Xuyu Cai; Nishma M. Ramzanali; Kiran Madwani; Goran Cabrilo; Debra L. Andrews; Yue Zhao; Milind Javle; E. Scott Kopetz; Rajyalakshmi Luthra; Hyunsung J. Kim; Sante Gnerre; Ravi Vijaya Satya; Han-Yu Chuang; Kristina M. Kruglyak; Jonathan Toung; Chen Zhao; Richard Shen; John V. Heymach; Funda Meric-Bernstam; Gordon B. Mills; Jian-Bing Fan; Neeraj S. Salathia
Letter to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds